Treatment of the mice with antisense oligonucleotides (ASOs) that deplete HDAC6 or PACS1 restores both neuronal structure and communication, suggesting PACS1R203W/HDAC6 underlies PACS1 syndrome neuronal pathology and that this NDD may be treatable with targeted therapies. This evidence concerns the gene HDAC6 and Neurodevelopmental delay.